Predictors of Treatment Response to Liraglutide in Type 2 Diabetes in a Real-World Setting

Acta Diabetologica- Italy

doi 10.1007/s00592-018-1124-0

Full Text

Abstract

Available in

Date

Authors

Publisher

Springer Science and Business Media LLC

Related search

Potential of Liraglutide in the Treatment of Patients With Type 2 Diabetes

Vascular Health and Risk Management
2009English

Pdb114 - Drug Utilization Study in Patients With Type 2 Diabetes Mellitus in an Italian Real-World Setting: A Retrospective Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Evaluating the Cost-Effectiveness of Liraglutide 1.8Mg Versus Lixisenatide 20μg for the Treatment of Type 2 Diabetes Mellitus in the Spanish Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Cost–benefit Comparison of Liraglutide and Sitagliptin in the Treatment of Type 2 Diabetes in Thailand

ClinicoEconomics and Outcomes Research
Health PolicyEconomicsEconometricsFinance
2019English

Lessons From a Cardiovascular Outcome Trial With Liraglutide in Type 2 Diabetes

Journal of Diabetes Investigation
Internal MedicineEndocrinologyMetabolismMedicineDiabetes
2017English

Cost Analysis of Treatment Success to Achieve a Clinically Relevant Composite Endpoint for Patients With Type-2 Diabetes on Liraglutide or Other Antidiabetic Therapies in a Chinese Setting

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Liraglutide as Add-On Therapy to Insulin in Type 2 Diabetes Mellitus: A Retrospective, Observational Study From a Daily Clinical Practice Setting in Switzerland

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2015English

Impact of Atherosclerotic Cardiovascular Disease on Healthcare Resource Utilization and Costs in Patients With Type 2 Diabetes Mellitus in a Real-World Setting

Clinical Diabetes and Endocrinology
EndocrinologyMetabolismDiabetes
2020English

A Real-World Observational Study of Time to Treatment Intensification Among Elderly Patients With Inadequately Controlled Type 2 Diabetes Mellitus

Journal of managed care & specialty pharmacy
Health PolicyPharmacyPharmaceutical Science
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy